Regeneration is the biological process by which living organisms regrow damaged or lost tissues, organs, or even entire body parts. It goes beyond simple wound healing: instead of patching an injury with scar tissue, regeneration restores the original structure and function. Some animals can regrow entire limbs, while humans regenerate certain tissues (like the liver) but default to scarring in most others. The differences come down to which molecular signals activate after an injury and whether cells can revert to a flexible, growth-ready state.
Three Types of Regeneration
Biologists recognize three distinct mechanisms, each defined by how cells behave after tissue is lost.
Epimorphosis is the most dramatic form. Mature cells at the wound site lose their specialized identity, reverting into an undifferentiated cluster called a blastema. That cluster then re-specializes to rebuild the missing structure from scratch. This is how salamanders regrow entire limbs, complete with bone, muscle, nerves, and skin.
Morphallaxis skips the growth phase almost entirely. Instead of producing new cells, the organism reshapes and repatterns the tissue it already has. Hydras, tiny freshwater animals, regenerate this way. Cut one in half, and the remaining tissue reorganizes itself into a smaller but complete animal with very little cell division involved.
Compensatory regeneration is the type most relevant to humans. Cells divide to replace lost tissue, but they stay specialized the whole time. They don’t form a blastema or reorganize existing tissue. They simply make more of themselves. The mammalian liver is the classic example.
What Humans Can and Cannot Regrow
The human body regenerates more than most people realize, but the capacity varies enormously by tissue type. The liver is the standout performer. Surgeons can remove up to 70% of a healthy liver, and the remaining tissue will divide until the organ returns to its original size, typically within three to six months. Liver function recovers even faster, normalizing within two to three weeks in patients with otherwise healthy livers. People with chronic liver disease can still regenerate, but the process is slower and less complete.
Peripheral nerves also regenerate, though at a pace that tests patience. After an injury, severed nerve fibers regrow at roughly 1 to 3 millimeters per day, the speed limited by how fast the cell can transport its internal scaffolding. For a nerve injury in the upper arm, that can mean months of waiting before sensation or movement returns to the hand. Three factors make recovery unpredictable: the supporting cells around the nerve gradually lose their regenerative signals the longer they wait for regrowth, the nerve cell body itself becomes less capable of pushing out new fibers over time, and regrowing fibers sometimes enter the wrong channel and connect to the wrong target.
The heart sits at the other end of the spectrum. For decades, scientists assumed adult heart muscle cells couldn’t regenerate at all. More recent work shows they do turn over, but slowly. At age 20, roughly 7% to 10% of heart muscle cells are replaced per year (slightly higher in women than men). By age 100, that rate climbs to 32% to 40% per year. While that sounds promising, it is nowhere near fast enough to repair the damage from a heart attack, which kills millions of cells in hours. The body fills that gap with scar tissue instead.
Why Scarring Wins Over Regeneration
When you cut your skin or injure a muscle, the default response is fibrosis: the body lays down tough, fibrous scar tissue to close the wound quickly. This is fast and effective for survival, but the scar doesn’t function like the original tissue. The question researchers are trying to answer is why some injuries trigger regeneration while others trigger scarring, sometimes in the very same body part.
The human fingertip offers a striking example. Amputations through the tip of the last finger bone, as long as the base of the nail bed remains intact, can regenerate bone and soft tissue. But amputate just a few millimeters further back, removing the nail matrix, and the finger heals with a scar instead. The difference traces to signaling molecules in the skin above the wound. In regenerative amputations, the wound skin activates a growth-promoting pathway (Wnt signaling) that recruits bone-building cells and nerve fibers into the wound. In non-regenerative amputations, that signal never turns on. Instead, the wound cells ramp up production of scar-related proteins and begin contracting the wound closed.
Interestingly, researchers have shown that transplanting cells producing the right chemical signals into a non-regenerative wound can partially rescue the process, coaxing the finger to regrow some bone where it otherwise wouldn’t. This suggests the difference between scarring and regeneration isn’t a hard genetic limit. It’s about whether the right molecular conversation happens at the right time.
How Salamanders Regrow Limbs
The axolotl, a Mexican salamander, is the most studied regenerator in biology. It can regrow legs, tail, portions of its heart, and even parts of its brain. The process starts when cells near the amputation site lose their specialized identity. Muscle cells, bone cells, and connective tissue cells all revert to a more flexible state, pooling together into a blastema at the wound surface.
The blastema acts like an embryonic limb bud. A specialized layer of skin called the apical epithelial cap forms over it and begins releasing growth signals, particularly fibroblast growth factors (FGFs), bone-building proteins (BMPs), and Wnt molecules. These are the same signaling families that guide limb development in an embryo. Nerves play a critical role too. Without nerve supply, the blastema fails to form. Researchers have shown that a cocktail of growth factors can substitute for nerve input and kickstart blastema growth in wounds that would otherwise not regenerate.
The blastema cells migrate toward these signals, proliferate, and gradually re-specialize into all the tissues of a new limb. The entire process, from amputation to functional limb, takes several weeks to months depending on the size of the animal and the amount of tissue lost.
Regenerative Medicine and Stem Cells
Since humans can’t naturally form blastemas, scientists are pursuing alternative strategies to unlock regeneration in tissues that normally scar. The most prominent approach involves induced pluripotent stem cells, or iPS cells. These are ordinary adult cells (often skin cells) that have been reprogrammed in the lab to behave like embryonic stem cells, capable of becoming virtually any cell type in the body.
The applications already demonstrated in animal models are wide-ranging. Nerve cells derived from iPS cells have been transplanted into the spinal cords of animals with contusive injuries, where they matured into functional neurons, helped insulate damaged nerve fibers, and improved the animals’ ability to walk. Dopamine-producing neurons grown from iPS cells have improved symptoms in rat models of Parkinson’s disease. Liver cells derived from iPS cells rescued mice from fatal liver failure. And in the heart, researchers have reprogrammed scar-forming cells directly into beating heart muscle cells, reducing the size of damaged areas after heart attacks.
Blood vessel engineering is another active area. Cells grown from iPS cells have been used to build functional blood vessels on scaffolds, and when transplanted into animals with blocked circulation, they improved blood flow recovery. The ability to generate blood vessels is considered one of the key bottlenecks for regenerating larger, more complex organs.
3D Bioprinting and Organ-Scale Regeneration
Building a full organ requires more than the right cells. It requires an intricate architecture of blood vessels, nerves, and structural support. 3D bioprinting aims to solve this by depositing living cells and supportive materials layer by layer into precise three-dimensional shapes.
Current techniques can fabricate small vascularized tissue patches using coaxial nozzles that simultaneously print a tube of cells and the crosslinking solution that solidifies around them, creating tiny perfusable channels that mimic blood vessels. Researchers have built vascularized heart tissue constructs by printing heart muscle cells alongside blood vessel-forming cells that self-organize into capillary networks within the printed structure.
The scale challenge remains enormous. A collaboration between United Therapeutics and 3D Systems produced a 3D-printed lung scaffold containing 44 trillion individual components, including 4,000 kilometers of capillary channels and 200 million air sacs, designed for gas exchange in animal models. The next step is seeding such scaffolds with a patient’s own stem cells to create transplantable organs. Fully functional bioprinted solid organs, hearts, kidneys, livers, lungs, are not yet available for clinical use, but the engineering infrastructure is advancing rapidly.
Pre-building blood vessel networks and nerve connections into printed tissues remains a prerequisite for any organ-scale construct. Without perfusion, cells deeper than about 200 micrometers from the surface starve for oxygen. Without innervation, the organ can’t integrate with the body’s control systems. Solving both problems simultaneously, at the resolution biology demands, is the central engineering challenge of the field.